Fundraising FoxBirk Venture
Venture capitalOslo · Seed–Growth · 2 people tracked
Find your way into Birk Venture
Sign up to see every warm intro you have to Birk Venture
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Birk Venture team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Birk Venture is a private evergreen investment company that invests exclusively in the life science sector, backing young companies with significant growth potential across pharmaceuticals, biotechnology, diagnostics, medical devices, and consumer health. It invests in both early-stage and more developed companies, seeking innovative technologies that address clear global medical needs, have achieved proof of concept or strong scientific acceptance, and are led by strong management and founders. The firm takes an active, long-term role in developing its portfolio companies, drawing on deep industrial experience from the pharmaceutical and biotech industry. Deal flow comes from universities, start-ups, spin-offs, and co-investors through a private investment consortium.
Source: firm website, verified Oct 3, 2026.
Team · 2 people
from the firm's website & public directories
What they invest in
from 8 of 11 portfolio companiesBiotech ×7Healthtech ×3Deep Tech ×2Medical Devices ×2Advanced Manufacturing ×1AI & Machine Learning ×1Developer Tools ×1E-commerce ×1
HQs:Norway×3United States×1
Investments · 11 tracked
founders shown can be your intro pathBy year:2024 · 12012 · 12011 · 13 dated
Accession Therapeutics develops cancer treatments by harnessing immune system mechanisms, with a focus on T cell receptor therapies and engineered cell therapies.
BiotechHealthtechMedical Devices
Alan Parker(CSO and Founder of Trocept)inBent Jakobsen(CEO and Founder)in
Co-investorsiGlobe Partners
Algeta was a Norwegian oncology company developing alpha-particle radiopharmaceuticals, notably Xofigo (radium-223 dichloride) for bone metastases in prostate cancer.
Co-investorsAdvent Life SciencesHealthCapAbingworth
APIM Therapeutics is a clinical-stage oncology company developing first-in-class PCNA-targeting peptide therapeutics that disrupt cellular stress responses and address treatment resistance in cancer.
BiotechHealthtech
Co-investorsSarsia Management AS
BerGenBio ASA was a company that merged with Oncoinvent ASA on 29 October 2025, with the combined entity renamed Oncoinvent.
Biotech
Co-investorsSarsia Management ASInvestinor
BiotechRadnor, US
Ruth Thieroff-Ekerdt(Executive Officer)Robert Lutz(Executive Officer)Alexander Lindstrom(Executive Officer)Matthew Pauls(Executive Officer)
BoardEigil Stray Spetalen(Director)Espen Tidemann Jorgensen(Director)
Co-investorsHealthCap
Nextera develops TCR-Like antibody drug candidates that target disease-specific pHLA antigens for cancer, autoimmune, and inflammatory diseases.
BiotechDeep Tech
Norwegian clinical-stage biotech developing radiopharmaceuticals for hematological cancers; listed 2015.
Co-investorsHealthCap
PCI Biotech develops bioprocessing technologies for manufacturing viral vectors and intracellular drug delivery solutions, serving immunotherapy and dermatology applications.
Advanced ManufacturingBiotechMedical DevicesOslo, NO
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Zelluna Immunotherapy
Exits · 1
1 acquisitionsAlgetaacq. by Bayer
Portfolio news
latest coverage across their companiesAccession Therapeutics · accessiontherapeutics.com · Mar 24, 2026
PCI Biotech · finance.yahoo.com · Jan 8, 2026
Frequently asked questions
- How many investments has Birk Venture made?
- Birk Venture has 11 tracked investments, 1 of which have exited.
- What stage does Birk Venture invest at?
- Birk Venture invests at the Seed, Series A, Growth stages.
- What sectors does Birk Venture focus on?
- Birk Venture focuses on Biotech, Healthtech, Medical Devices, Wellness & Fitness.
- Where is Birk Venture located?
- Birk Venture is headquartered in Oslo, NO.
- Who does Birk Venture co-invest with?
- Birk Venture most often shares deals with HealthCap, Sarsia Management AS, Advent Life Sciences, among 3 tracked co-investors.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.
Seventure Partners is a European venture capital firm backing innovative companies across life sciences and digital technologies, with additional focus areas in sport & performance and the blue economy.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
Alkemi Growth Capital is an India-focused early-stage growth fund investing exclusively in scalable healthcare and wellness companies with validated product-market fit and a clear pathway to institutional scale.